Steve Lewis

Archimedes Capital invests in a variety of venture capital and private equity deals ranging from seed stage to pre-IPO or later. The firm focuses on identifying and investing in opportunities that utilize or can be accelerated to success through a global competitive advantage. They target companies located outside of the US with resources and operating practices involving world-class, low-cost research & development and manufacturing practices with the potential to dramatically improve operating economics. Archimedes Capital also targets companies with the ability to sell into large and willing global markets and that maximize early customer traction and overall revenues. The firm significant US capital, US management, US liquidity and core technology expertise which they strive to combine with the strengths and markets the rest of the world has to offer on order to reduce capital requirements, reduce risk and improve investment returns.

Provides management and technology consulting services

Develops and manufactures marijuana,alcohol breathalyzers using biomarker detection technology to measure recent THC use from breath samples